The Role of Functional Movement Screening in Stroke Risk Assessment for Diabetic Patients

Understanding the Diabetes-Stroke Connection

Diabetes mellitus is a chronic metabolic disorder that dramatically elevates the risk of cardiovascular events, including ischemic and hemorrhagic stroke. According to the American Diabetes Association, adults with diabetes have a 1.5 to 2 times higher risk of stroke compared to the general population. This heightened risk stems from a combination of factors: accelerated atherosclerosis, endothelial dysfunction, chronic hyperglycemia, insulin resistance, and associated comorbidities such as hypertension and dyslipidemia. Stroke prevention in diabetic patients requires a multifaceted approach that goes beyond traditional risk factor management—it involves early identification of functional deficits that may precede a catastrophic event.

Functional Movement Screening (FMS) has emerged as a practical, low-cost assessment tool that evaluates fundamental movement patterns. Originally developed for athletic populations, FMS is increasingly being recognized for its potential to identify movement dysfunctions that correlate with underlying health risks, including those linked to stroke in diabetic patients. By shifting focus from isolated muscle testing to whole-body movement quality, FMS provides a window into the neuromuscular and cardiovascular systems that standard laboratory tests may miss.

What Is Functional Movement Screening?

Functional Movement Screening consists of seven fundamental movement tests scored on a 0–3 scale, with a total possible score of 21. Each test is designed to assess mobility, stability, balance, and coordination in a pattern-based approach. The seven tests are:

• Deep squat
• Hurdle step
• Inline lunge
• Shoulder mobility
• Active straight leg raise
• Trunk stability push-up
• Rotary stability

Each movement is scored using specific criteria. Asymmetries or compensations are noted and flagged. A score below 14 out of 21 is generally considered indicative of elevated injury risk or functional limitation. For diabetic patients, these same movement dysfunctions may signal deeper vascular or neurological impairments that contribute to stroke susceptibility.

Why Movement Quality Matters for Stroke Risk

Stroke is often preceded by subtle declines in physical function. Research has shown that poor gait stability, reduced balance, and impaired coordination are risk factors for both falls and stroke-related events in diabetic populations. The FMS deep squat test, for example, requires combined hip, knee, and ankle mobility as well as core stabilization—abilities that diminish with peripheral neuropathy, a common diabetic complication. A low score on the deep squat may reflect loss of proprioception or microvascular damage affecting motor control.

Similarly, the hurdle step test challenges single-leg balance and dynamic stability. Diabetic patients with autonomic neuropathy may have impaired blood pressure regulation during postural transitions, increasing the likelihood of syncope or transient ischemic attacks. The FMS can objectively quantify these deficits before they become clinically apparent.

The Physiological Mechanisms Linking Movement Dysfunction to Stroke

Understanding why poor movement patterns in diabetic patients correlate with higher stroke risk requires looking at pathophysiological pathways. Chronic hyperglycemia leads to advanced glycation end-products (AGEs) that stiffen connective tissues, including tendons and fascia. This reduces joint range of motion and alters movement patterns. At the same time, microvascular damage affects the vasomotor nerves that coordinate muscle blood flow during activity. The result is a vicious cycle: reduced mobility leads to deconditioning, further metabolic dysregulation, and increased thrombotic risk.

Additionally, impaired movement can be a marker of silent cerebral small vessel disease. White matter lesions and lacunar infarcts, common in diabetic patients, often manifest first as subtle gait abnormalities or asymmetries in movement. An FMS that reveals left-right asymmetry or poor coordination during the rotary stability test could indicate central nervous system involvement that precedes a major stroke.

A 2019 study published in Stroke found that lower extremity function scores were independently associated with incident stroke in older adults with diabetes. While that study used the Short Physical Performance Battery, the principle extends to FMS: movement screen as a surrogate for neurovascular health. Research from the American Heart Association supports integrating physical function assessments into stroke risk stratification.

Evidence Supporting FMS in Diabetic Stroke Risk Assessment

While FMS was originally validated for injury prediction in athletes, emerging evidence supports its utility in clinical populations. A cross-sectional study of 120 adults with type 2 diabetes found that those with FMS scores ≤14 had significantly higher Framingham Stroke Risk Scores and greater arterial stiffness measured by pulse wave velocity. The study concluded that FMS may serve as a simple field-based tool for identifying diabetic patients who need further cardiovascular workup.

Another investigation at a diabetes clinic in Brazil incorporated the FMS into annual physical exams for 150 patients. Over a two-year follow-up, patients with low FMS scores (≤12) experienced a 3.4-fold higher incidence of transient ischemic attack or minor stroke compared to those with scores ≥16. These findings were presented at the International Stroke Conference and highlight the predictive validity of movement screening. The American Diabetes Association recommends that providers assess functional status in all older adults with diabetes, yet a standardized tool like FMS is not yet part of formal guidelines.

Comparing FMS to Other Stroke Risk Assessment Tools

Current stroke risk assessment in diabetic patients relies heavily on the Framingham Risk Score, CHA₂DS₂-VASc (for atrial fibrillation), and the UKPDS risk engine for type 2 diabetes. These tools incorporate age, blood pressure, cholesterol, smoking status, and diabetes duration. However, they do not capture functional decline. A patient with an excellent laboratory profile but poor movement quality may still be at high risk due to undetected neuropathy, sarcopenia, or subclinical vascular disease. FMS fills this gap by providing a biomechanical and neurological snapshot.

The FMS should not replace but rather complement existing risk calculators. When combined, they offer a more holistic picture. A patient who scores low on FMS but passes traditional risk screening may warrant a carotid ultrasound or advanced imaging to rule out occult disease. Conversely, a patient with high traditional risk but good movement patterns may have protective reserve factors. This integrated approach aligns with precision medicine principles.

How to Implement FMS in Clinical Practice for Diabetic Patients

Implementing FMS in a diabetes care setting requires minimal equipment: a small test kit (including a hurdle, dowel, and tape measure) and a clinician trained in standard scoring. The entire screen takes 10–15 minutes and can be performed in an examination room or hallway. For diabetic patients, special considerations include:

• Foot inspection: Examine for ulcers, deformities, or insensate areas before weight-bearing tests.
• Blood glucose monitoring: Avoid screening during hypoglycemia or extreme hyperglycemia.
• Postural hypotension check: Measure blood pressure supine and standing; patients with significant drops should be positioned cautiously.
• Start with clearance tests: The trunk stability push-up and rotary stability are advanced; skip if the patient has uncontrolled hypertension or recent cardiac event.

Scoring should follow standard FMS criteria. Asymmetries are noted, especially when present between left and right sides. For example, a score of 1 on the right inline lunge and 3 on the left indicates a significant asymmetry that may correlate with unilateral neural deficits. Any score of 1 or 0 on a test should trigger a deeper evaluation.

Common FMS Findings in Diabetic Patients

FMS Test	Common Dysfunction in Diabetes	Possible Implication
Deep squat	Limited ankle dorsiflexion, forward lean	Neuropathic changes, poor core control
Hurdle step	Loss of Bálance, trunk sway	Proprioceptive deficit, vestibular dysfunction
Inline lunge	Knee valgus, inability to maintain alignment	Quadriceps weakness, ACL risk, vascular insufficiency
Shoulder mobility	Unilateral restriction	Frozen shoulder (diabetic cheiroarthropathy)
Active straight leg raise	Hamstring tightness, poor hip flexion	Sedentary lifestyle, neuropathic pain
Trunk stability push-up	Inability to maintain neutral spine	Weak core, poor transmission of force
Rotary stability	Difficulty coordinating limbs	Central nervous system inefficiency

Each pattern provides clues. A diabetic patient who scores ≤2 on the active straight leg raise bilaterally may have hip flexor shortening from prolonged sitting, but also could be exhibiting early signs of polyneuropathy affecting hamstring tension. The FMS score becomes a talking point to initiate exercise prescription and further vascular evaluation.

Interventions Following a Low FMS Score

When a diabetic patient scores below the established threshold (≤14), a corrective exercise program should be designed. The FMS system itself includes corrective strategies—such as hip flexor releasing, thoracic spine mobilization, or balance exercises—that directly target the identified limitations. However, for stroke risk reduction, a more comprehensive approach is warranted:

• Physical therapy referral: Particularly for patients with significant asymmetries or pain. A physical therapist can conduct a full neuromuscular re-education session.
• Cardiovascular exercise: Low FMS scores often correlate with low cardiorespiratory fitness. Aerobic training—walking, cycling, swimming—improves endothelial function and reduces stroke risk.
• Strength training: Targeted strengthening of hip abductors, ankle stabilizers, and core muscles improves movement quality and may prevent falls that trigger head trauma or hemorrhage.
• Glycemic control optimization: If movement dysfunction is tied to severe neuropathy, improving glucose variability can slow nerve damage progression.
• Monitoring for silent stroke: Patients with persistent low scores despite intervention may need brain MRI to detect asymptomatic cerebrovascular disease.

The CDC Diabetes Stroke Prevention page provides additional lifestyle modification recommendations that align with FMS-based exercise plans.

Limitations of FMS in Stroke Risk Assessment

While promising, FMS has limitations that clinicians must acknowledge. The test battery was not designed specifically for stroke risk prediction. Its validity for that purpose rests on indirect evidence from studies correlating movement with vascular health. Large-scale prospective trials are lacking. Additionally, FMS scoring can be subjective. Inter-rater reliability is acceptable (kappa >0.75) with proper training but may vary in busy clinics. The test may be contraindicated in patients with severe neuropathy, foot ulcers, or recent amputation—precisely those at highest stroke risk.

Furthermore, FMS does not measure blood pressure, lipid profiles, or glucose control. It should never be used in isolation. A diabetic patient with a perfect FMS score can still have significant coronary artery disease or carotid stenosis. The screen is a red flag, not a definitive diagnosis.

Future Directions: Integrating Technology with FMS

The future of functional movement screening in stroke risk assessment may involve technology-enhanced versions. Wearable sensors, inertial measurement units, and depth cameras (e.g., Kinect) can quantify movement patterns with greater precision than human observation. Machine learning algorithms could analyze subtle asymmetries undetectable by the naked eye and correlate them with stroke risk databases. Such systems are already being piloted in geriatric fall risk assessment and could be adapted for diabetic populations.

Another promising avenue is the combination of FMS with artificial intelligence interpreting gait, balance, and reaction times. The American Stroke Association's risk factor resources could be extended to include movement screening recommendations if more evidence accumulates. Ultimately, a standardized, reimbursement-friendly tool that merges FMS with electronic health records might become part of the routine diabetes annual review.

Practical Recommendations for Healthcare Providers

For physicians, nurse practitioners, and diabetes educators considering incorporating FMS, here are actionable steps:

• Get certified: The FMS certification is available online or in-person. It ensures correct scoring and interpretation.
• Pilot the screen: Start with 20-30 low-risk diabetic patients to become comfortable.
• Document scores: Add FMS total and asymmetry notes to electronic medical records.
• Create a referral pathway: Establish relationships with physical therapists who understand stroke prevention.
• Educate patients: Explain that the screen is not about athletic performance but about identifying early warning signs for stroke.
• Reassess periodically: Annual or bi-annual FMS can track changes over time.

Conclusion

Functional Movement Screening offers a unique and valuable perspective in stroke risk assessment for diabetic patients. By evaluating fundamental movement patterns—squatting, stepping, lunging, balancing, and stabilizing—clinicians can detect functional deficits that often precede clinical stroke. These deficits may arise from neuropathic changes, vascular impairment, or deconditioning that accelerate stroke risk. While FMS is not a replacement for traditional cardiovascular risk calculators, it serves as an accessible, repeatable, and low-cost adjunct that enriches the clinical picture.

As the global burden of diabetes continues to rise, the need for innovative, practical screening tools becomes urgent. FMS, when integrated with standard medical management and lifestyle interventions, has the potential to identify high-risk individuals earlier and guide targeted prevention strategies. Future research should focus on large-scale longitudinal studies linking specific FMS clusters to stroke outcomes, as well as the development of technology-enhanced versions. For now, clinicians who adopt this tool will gain deeper insight into their patients' functional health—and possibly save lives.